Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric citrate vs sevelamer carbonate in CKD hemodialysis hyperphosphatemia
CTR20180674Phase 3Suspended
- Sponsor
- Carephar
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ferric citrate in hyperphosphatemia, chronic kidney disease (CKD), end-stage kidney disease (ESKD), sponsored by Carephar. Started Jun 2018; status: suspended.
02
Drugs
ferric citrate
03
Conditions
hyperphosphatemiachronic kidney disease (CKD)end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on CTR20180674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180674.